CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE. (2013). Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013031. https://doi.org/10.4084/mjhid.2013.031